Compression Therapy Market To Reach USD 7.3 Billion By 2033

Trishita Deb
Trishita Deb

Updated · Sep 10, 2024

SHARE:

Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Learn more.
close
Advertiser Disclosure

At Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Media. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Introduction

Global Compression Therapy Market size is expected to be worth around USD 7.3 Billion by 2033 from USD 4.1 Billion in 2023, growing at a CAGR of 5.9% during the forecast period from 2024 to 2033.

Medical compression therapy involves the use of elastic devices to apply controlled pressure to limbs or other body areas. This pressure helps to compress vein walls, improving circulation. Typically, compression therapy is utilized after surgery to reduce swelling and improve leg circulation. When walking, calf muscles regularly contract and relax, aiding blood flow from the lower extremities to the heart. However, immobility for extended periods, such as during post-surgery recovery, can lead to blood clots.

The National Blood Clot Alliance reported that annually, between 100,000 and 300,000 deaths are attributed to blood clots. This figure surpasses the combined number of deaths caused by AIDS, breast cancer, and car accidents. Additionally, the National Center for Biotechnology Information (NCBI) stated in 2018 that lymphedema is a global concern, affecting approximately 250 million people worldwide.

Compression therapy is also effective in reducing edema and creating favorable conditions for treating acute inflammatory conditions. Common treatments on the market include ulnar nerve entrapment therapy, fractured spine treatments, compression fracture therapy, and leg compression therapy. The increasing number of elderly individuals and rising sports-related injuries are key factors driving the global compression therapy market.

Furthermore, according to the World Health Organization (WHO) update in 2021, rehabilitation is a critical part of universal health coverage. Along with promoting good health, preventing diseases, and providing treatment and palliative care, compression therapy plays a role in rehabilitation. Several benefits are associated with this therapy, which is expected to drive its market growth.

Compression Therapy Market Growth

Key Takeaways

  • Market Size: Compression Therapy Market size is expected to be worth around USD 7.3 Billion by 2033 from USD 4.1 Billion in 2023.
  • Market Growth: The market growing at a CAGR of 5.9% during the forecast period from 2024 to 2033.
  • Technique Analysis: Static compression technique dominated the market in 2023 (53.7% share).
  • Product Preference: Compression bandages account for 38% market share, favored for treating edema and venous disorders in the lower limb.
  • Application Focus: Varicose vein treatment holds a significant market share of 34.5% in 2023, demonstrating a growing preference for compression therapy in managing this condition.
  • Distribution Dynamics: Hospitals & clinics dominate distribution with a 53% market share in 2023, while e-commerce platforms exhibit the fastest growth.
  • Regional Dominance: North America leads with a 36.2% market share, amounting to USD 1.48 Billion, driven by an aging population and rising obesity rates.

Compression Therapy Statistics

Healthcare Provider Participation:

  • A total of 891 healthcare providers participated in the study, consisting of 3.3% physicians, 5.5% medical assistants, and 90.7% nursing staff.
  • The study included 177 patients, with an average age of 69.4 years, of whom 75.1% were women.

Application of Compression Therapy:

  • Fewer than 10% of participants applied compression bandages with the intended pressure of 50-60 mmHg.
  • 77% of participants applied bandages with pressure below the target range, while 13.7% applied pressure above the recommended range.
  • Only 11.9% of healthcare providers were aware of the need to use padding beneath compression bandages, and 15% were familiar with multi-component compression systems.
  • Additionally, only 14.8% of providers were familiar with ulcer stocking systems.

Patient Usage of Compression Therapy:

  • Of the patients, 31.1% received no compression therapy, 40.1% used bandages, and 28.8% wore stockings.
  • Among patients using stockings, 67.4% used compression class II, 13.7% used class III, and 19.6% used class I.
  • Most patients (70.6%) put on their stockings after getting out of bed, while 21.1% wore them both day and night.

Effectiveness of Compression Therapy:

  • Compression therapy shows a high success rate, with a 97% healing rate for patients who follow the treatment plan correctly.
  • In studies assessing five different compression therapies, healing rates after two months ranged from 16.66% (least effective) to 58.62% (most effective).

Challenges and Compliance:

  • Discomfort was a common issue, with 39.2% of patients experiencing discomfort while wearing stockings, and only 11.7% had a device to assist with donning.
  • Nearly half (49.4%) of patients found compression therapy uncomfortable, and 34.5% had difficulty putting on the compression garments.
  • Adherence to prescribed therapy was low, with only 31.8% of patients wearing compression therapy as prescribed, and 8.5% not using it at all.

Venous Leg Ulcer (VLU) Insights:

  • Globally, between 1% and 2% of the population will experience a venous leg ulcer in their lifetime, with the prevalence rising to 3%-5% in individuals over 65.
  • VLUs account for 60%-70% of all leg ulcers, and without proper treatment, the recurrence rate can reach up to 67%.
  • In the U.S., around 80% of lower leg ulcers are caused by chronic venous disease, for which compression therapy is the primary treatment.

Global and Regional Data:

  • In Germany, venous leg ulcers are the most common type of chronic leg ulcer, accounting for up to 70% of cases. Between 67% and 83% of patients with VLUs use short-stretch bandages for compression therapy.
  • In the UK, venous leg ulcers affect 0.1%-0.3% of the population, with a 1% lifetime risk. Approximately 53% of these ulcers heal within 12 months, although around half of the patients receive inadequate care.

Emerging Trends

  • Increased Home-Based Therapy Options: The demand for home-based compression therapy options is rising due to their convenience and cost-effectiveness, allowing patients to manage conditions like lymphedema and venous diseases comfortably at home.
  • Technological Advancements: There is a growing integration of technology in compression devices, including the development of smart garments and wearable technology that provide real-time monitoring and adjustment of compression levels.
  • Expanding Insurance Coverage: Legislative changes, like the inclusion of certain compression therapy items in Medicare under recent acts, are broadening patient access to necessary treatments.
  • Enhanced Patient Education and Training: There is an increasing emphasis on educating patients and healthcare providers about the proper application and benefits of compression therapy to improve adherence and outcomes.
  • Pneumatic Compression Devices: The use of pneumatic compression devices is expanding, particularly for preventing deep vein thrombosis in post-surgical patients and those with limited mobility.
  • Focus on Preventative Applications: Compression therapy is being increasingly recommended as a preventative measure for high-risk individuals to prevent venous thromboembolism, especially in immobilized patients.
  • Customization and Personalization: Advances in material science are enabling more personalized and tailored compression therapy solutions to meet individual patient needs and preferences, enhancing comfort and effectiveness.
  • Market Expansion: The global market for compression therapy is growing due to increasing awareness of the benefits of compression therapy and an aging population prone to circulatory diseases.
  • Regulatory Focus: There is ongoing research and regulatory focus on ensuring the safety and efficacy of new compression therapy products entering the market, driven by healthcare regulations and patient safety standards.
  • Collaborations and Partnerships: Companies are increasingly entering into partnerships and collaborations to innovate and expand the reach of advanced compression therapy solutions across different regions.

Use Cases

  • Lymphedema Management: Compression therapy is essential for managing lymphedema, helping to prevent fluid accumulation in tissues and facilitating fluid movement out of affected areas.
  • Venous Ulcer Treatment: It’s widely used to treat venous ulcers by improving blood flow and reducing venous pressure, which accelerates healing and reduces recurrence.
  • Deep Vein Thrombosis Prevention: For patients at risk of deep vein thrombosis, especially after surgery or during prolonged immobility, compression therapy helps maintain blood flow and reduce clot formation.
  • Varicose Veins: Compression garments can alleviate the discomfort and swelling associated with varicose veins by helping to push blood back towards the heart.
  • Post-thrombotic Syndrome Management: Compression stockings are often prescribed to manage post-thrombotic syndrome symptoms, such as swelling and pain, following a deep vein thrombosis episode.
  • Edema Reduction: It is beneficial in reducing edema in patients with various medical conditions by enhancing fluid clearance from interstitial spaces.
  • Sport Injury Recovery: Athletes often use compression therapy to speed up recovery from muscle strains and sprains by reducing swelling and fatigue.
  • Pregnancy Support: Pregnant women may use compression therapy to relieve discomfort and swelling in the legs and to prevent venous issues like varicose veins.
  • Enhancement of Athletic Performance: Compression garments are used by athletes during performance to reduce muscle oscillation and fatigue, and post-exercise for recovery.
  • Sclerotherapy Support: After sclerotherapy for varicose veins, compression stockings are used to help close the treated veins, ensuring the success of the procedure.

Conclusion

Compression therapy is a vital and growing component of healthcare, particularly in the management of circulatory and lymphatic disorders. Its effectiveness in improving blood flow, reducing edema, and accelerating healing is demonstrated across various medical applications, from post-surgery recovery to chronic condition management. Despite challenges in adherence and patient comfort, technological advancements and increased educational efforts are enhancing therapy outcomes. With the global market expected to expand significantly, driven by an aging population and advancements in treatment modalities, compression therapy remains a critical tool in enhancing patient quality of life and managing prevalent health conditions.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

SHARE:
Trishita Deb

Trishita Deb

Trishita has more than 8+ years of experience in market research and consulting industry. She has worked in various domains including healthcare, consumer goods, and materials. Her expertise lies majorly in healthcare and has worked on more than 400 healthcare reports throughout her career.

Request a Sample Report
We'll get back to you as quickly as possible